<DOC>
	<DOCNO>NCT00725686</DOCNO>
	<brief_summary>The aim study evaluate whether PF-04523655 safe treatment neovascular/wet AMD</brief_summary>
	<brief_title>Study PF-04523655 ( REDD14NP ) In Subjects With Choroidal Neovascularization ( CNV ) Secondary Age-Related Macular Degeneration ( Wet AMD )</brief_title>
	<detailed_description>Dose escalation safety study</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<criteria>Patient ≥ 50 year old general good health . Patients medically control chronic disease HTN , AODM , hyperlipidemia may include . Patient capable give consent . Patient willing able comply visit schedule study procedure include followup visit . Patient document CNV secondary AMD evidence active disease characterize blood vessel leakage evidence hemorrhage . Patient clear ocular medium adequate pupil dilation allow good quality image fundus photography . Patient 's intraocular pressure ≤ 25 mmHg Patient childbearing potential . Every female patient consider childbearing potential unless sterilization surgery postmenopausal menstrual period least 12 month . Patient CNV due cause AMD , include ocular periocular infection . Patient lesion easily image quantify . Patient underlying systemic disease cardiac , neurological , infectious disease , uncontrolled diabetes mellitis , disease eye AMD . Patient may medically control glaucoma . Patient participate concurrent interventional study .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Choroidal Neovascularization ( CNV ) `` WET '' AMD</keyword>
</DOC>